Cart
sales@molnova.com
Sulfamethoxazole sodium
CAS No. 4563-84-2
Sulfamethoxazole sodium( Ro 4-2130 sodium )
Catalog No. M21187 CAS No. 4563-84-2
Sulfamethoxazole sodium is a sulfonamide bacteriostatic antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 35 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 54 | In Stock |
|
| 1G | 79 | In Stock |
|
Biological Information
-
Product NameSulfamethoxazole sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfamethoxazole sodium is a sulfonamide bacteriostatic antibiotic.
-
DescriptionSulfamethoxazole sodium is a sulfonamide bacteriostatic antibiotic.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 4-2130 sodium
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research AreaInfection
-
Indicationurinary?tract?infection
Chemical Information
-
CAS Number4563-84-2
-
Formula Weight275.26
-
Molecular FormulaC10H10N3NaO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:55 mg/mL (199.81 mM)
-
SMILESCc1cc([N-]S(=O)(=O)c2ccc(N)cc2)no1.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yuriko Fujiwara Naoko et al. Contact urticaria syndrome caused by sulfamethoxazole sodium contained in eye drops[J]. Contact Dermatitis 2017.
molnova catalog
related products
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
-
BENZOFURAN-3-CARBALD...
BENZOFURAN-3-CARBALDEHYDE is a natural product.
-
Tyr-Uroguanylin (rat...
Tyr-Uroguanylin (rat)
